Amlie Mtivier - AEZS Old Assistant Sec
Insider
Amlie Mtivier is Assistant Sec of AEZS Old
| Phone | 843 900 3223 |
| Web | https://www.zentaris.com |
AEZS Old Management Efficiency
The company has return on total asset (ROA) of (0.2996) % which means that it has lost $0.2996 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8171) %, meaning that it created substantial loss on money invested by shareholders. AEZS Old's management efficiency ratios could be used to measure how well AEZS Old manages its routine affairs as well as how well it operates its assets and liabilities.AEZS Old currently holds 277.57 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. AEZS Old has a current ratio of 9.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about AEZS Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Anna Moore | Transcode Therapeutics | 63 | |
| FACP MD | Moleculin Biotech | 70 | |
| Peter MBA | Bio Path Holdings | 75 | |
| David Jin | Avenue Therapeutics | 34 | |
| Stephen Kilmer | Ibio Inc | N/A | |
| Melissa Berquist | Ibio Inc | N/A | |
| Laxminarayan Bhat | Reviva Pharmaceuticals Holdings | 60 | |
| CPA JD | Jaguar Animal Health | 60 | |
| Alexandra MD | Avenue Therapeutics | 58 | |
| Jack Reich | Adial Pharmaceuticals | 75 | |
| Victoria Rac | Bio Path Holdings | N/A | |
| Mark Peikin | Adial Pharmaceuticals | N/A | |
| Jacqueline Northcut | Moleculin Biotech | 62 | |
| Qiyong Liu | Transcode Therapeutics | 60 | |
| Seth MD | Tonix Pharmaceuticals Holding | 67 | |
| Robert Dudley | Transcode Therapeutics | 73 | |
| CPA CPA | Tonix Pharmaceuticals Holding | 50 | |
| Donald Picker | Moleculin Biotech | 79 | |
| Thomas III | Ibio Inc | 57 | |
| DVM MS | Jaguar Animal Health | N/A | |
| Louis Ploth | Moleculin Biotech | 70 | |
Management Performance
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 |
AEZS Old Leadership Team
Elected by the shareholders, the AEZS Old's board of directors comprises two types of representatives: AEZS Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AEZS. The board's role is to monitor AEZS Old's management team and ensure that shareholders' interests are well served. AEZS Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AEZS Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Klaus Paulini, CEO President | ||
| Amlie Mtivier, Assistant Sec | ||
| Eckhard Guenther, Sr Germany | ||
| ICDD MBA, CEO President | ||
| Giuliano Fratta, Senior CFO | ||
| Matthias Gerlach, Senior Production | ||
| Nicola MD, Chief Development | ||
| Michael Teifel, Vice President - Non-Clinical Sciences |
AEZS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AEZS Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.82 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 15.15 M | |||
| Shares Outstanding | 3.06 M | |||
| Shares Owned By Insiders | 1.32 % | |||
| Shares Owned By Institutions | 5.21 % | |||
| Number Of Shares Shorted | 5.27 K | |||
| Price To Earning | 15.42 X | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 7.60 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in AEZS Stock
If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |